Comments on: Take two ximelegatran and call me in the morning http://www.journalclub.org/2005/02/13/n56 Comments on the medical literature Wed, 13 Jul 2005 13:30:08 +0000 hourly 1 http://wordpress.org/?v=3.0.1 By: charles http://www.journalclub.org/2005/02/13/n56/comment-page-1#comment-1046 charles Sat, 12 Mar 2005 05:57:13 +0000 http://www.journalclub.org/2005/02/09/n56#comment-1046 a good review... thank you! a good review… thank you!

]]> By: Matt http://www.journalclub.org/2005/02/13/n56/comment-page-1#comment-739 Matt Mon, 14 Feb 2005 19:37:33 +0000 http://www.journalclub.org/2005/02/09/n56#comment-739 Already a dead issue basically...failed to pass an FDA advisory panel in 2004. Every analyst looking at AZN has written the drug off completely. Already a dead issue basically…failed to pass an FDA advisory panel in 2004. Every analyst looking at AZN has written the drug off completely.

]]> By: Cardio NP http://www.journalclub.org/2005/02/13/n56/comment-page-1#comment-738 Cardio NP Mon, 14 Feb 2005 06:24:05 +0000 http://www.journalclub.org/2005/02/09/n56#comment-738 The chief of our cardiology dept had high hopes for this drug - thought it would replace coumadin. However, he now feels that the FDA won't even approve it given the liver toxicity. (Who wants to revisit troglitazone?) The chief of our cardiology dept had high hopes for this drug – thought it would replace coumadin. However, he now feels that the FDA won’t even approve it given the liver toxicity.
(Who wants to revisit troglitazone?)

]]>